Cite
HARVARD Citation
Ma, S. et al. (2018). Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma. Thoracic cancer. 9 (2), pp. 310-315. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, S. et al. (2018). Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma. Thoracic cancer. 9 (2), pp. 310-315. [Online].